Profile data is unavailable for this security.
About the company
Argenica Therapeutics Limited is an Australia-based biotechnology company, developing novel therapeutics to reduce brain tissue death after stroke and other types of brain injury and neurodegenerative diseases to improve patient outcomes. The Company's lead neuroprotective peptide candidate, ARG-007, has been demonstrated to improve outcomes in pre-clinical stroke models, traumatic brain injury (TBI) and hypoxic ischemic encephalopathy (HIE). The Company has completed a Phase I clinical trial in healthy human volunteers to assess the safety and tolerability of a single dose of ARG-007. It has completed dosing in a Phase II clinical trial in ischaemic stroke patients and continues to generate preclinical data in other neurological conditions, including in TBI and HIE.
- Revenue in AUD (TTM)332.69k
- Net income in AUD-9.80m
- Incorporated2019
- Employees--
- LocationArgenica Therapeutics Ltd4/117 BroadwayNEDLANDS 6009AustraliaAUS
- Phone+61 89329-3396
- Websitehttps://argenica.com.au/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Neurotech International Ltd | 2.58m | -10.60m | 18.15m | -- | -- | 4.97 | -- | 7.03 | -0.0103 | -0.0103 | 0.0025 | 0.0028 | 0.3341 | -- | 12.69 | -- | -137.17 | -130.68 | -142.71 | -148.27 | 4.41 | -- | -410.57 | -428.93 | 11.34 | -- | 0.00 | -- | -22.61 | 99.30 | -109.08 | -- | -- | -- |
| Patrys Ltd | 828.54k | -3.01m | 18.20m | 15.00 | -- | 10.30 | -- | 21.97 | -0.0156 | -0.0156 | 0.0043 | 0.0033 | 0.2808 | -- | 0.7647 | -- | -102.13 | -58.09 | -143.30 | -63.36 | -- | -- | -363.69 | -250.93 | -- | -- | 0.00 | -- | -40.57 | 1.40 | 14.86 | -- | -- | -- |
| IDT Australia Ltd | 19.86m | -8.06m | 20.09m | 156.00 | -- | 0.9227 | -- | 1.01 | -0.0189 | -0.0189 | 0.0465 | 0.0509 | 0.5817 | 2.60 | 2.59 | -- | -23.61 | -13.43 | -29.19 | -16.06 | 69.19 | 79.42 | -40.60 | -30.01 | 2.36 | -9.62 | 0.3222 | -- | 40.65 | 6.99 | -48.96 | -- | 11.30 | -- |
| Noxopharm Ltd | 2.83m | -4.88m | 21.33m | 1.00k | -- | 30.92 | -- | 7.54 | -0.0167 | -0.0167 | 0.0097 | 0.0024 | 0.4979 | -- | 1.06 | -- | -85.95 | -49.70 | -156.33 | -59.16 | -- | -- | -172.63 | -229.01 | -- | -- | 0.7823 | -- | 17.54 | -19.45 | -36.50 | -- | -- | -- |
| BTC Health Ltd | 9.96k | 3.98m | 25.02m | 1.00 | 6.01 | 2.49 | 6.28 | 2,512.23 | 0.0117 | 0.0117 | 0.00003 | 0.0282 | 0.0014 | -- | -- | -- | 54.89 | -13.71 | 56.47 | -14.66 | -- | -- | 39,972.79 | -3,966.34 | -- | -- | 0.00 | -- | -39.12 | -43.28 | 277.27 | -- | -- | -- |
| Holista Colltech Limited | 5.83m | 584.85k | 28.32m | 3.00 | 35.00 | -- | 43.80 | 4.86 | 0.0022 | 0.0023 | 0.0195 | -0.0016 | 1.76 | 3.83 | 5.84 | -- | 17.53 | -46.13 | -- | -85.40 | 49.66 | 55.15 | 9.98 | -38.85 | 0.3782 | 3.93 | -- | -- | -5.82 | -5.07 | 97.92 | -- | -37.01 | -- |
| Argenica Therapeutics Ltd | 332.69k | -9.80m | 33.40m | -- | -- | 9.70 | -- | 100.39 | -0.0762 | -0.0762 | 0.0026 | 0.0268 | 0.0323 | -- | 1.79 | -- | -95.10 | -47.11 | -117.81 | -55.90 | -- | -- | -2,945.67 | -2,938.71 | -- | -40,666.84 | 0.00 | -- | 166.93 | 359.61 | -30.86 | -- | -- | -- |
| Algorae Pharmaceuticals Ltd | 141.05k | -802.96k | 33.78m | -- | -- | 15.14 | -- | 239.46 | -0.0005 | -0.0005 | 0.00008 | 0.0013 | 0.0505 | -- | 3.38 | -- | -28.72 | -51.95 | -30.63 | -56.76 | -- | -- | -569.27 | -1,452.78 | -- | -- | 0.00 | -- | 12.66 | -23.93 | 61.68 | -- | -- | -- |
| Neuroscientific Biopharmaceuticals Ltd | 166.08k | -1.85m | 39.91m | -- | -- | 2.37 | -- | 240.30 | -0.0126 | -0.0126 | 0.0011 | 0.0506 | 0.0148 | -- | 2.17 | -- | -16.48 | -37.13 | -16.65 | -40.11 | -- | -- | -1,111.22 | -185.57 | -- | -746.17 | 0.00 | -- | -93.05 | 16.84 | -669.23 | -- | -- | -- |
| Anteotech Ltd | 1.03m | -6.76m | 41.62m | 40.00 | -- | 12.02 | -- | 40.50 | -0.0025 | -0.0025 | 0.0004 | 0.0012 | 0.1299 | -- | 6.90 | -- | -85.41 | -76.84 | -106.22 | -87.65 | -- | -- | -657.69 | -1,253.69 | -- | -- | 0.3835 | -- | 99.60 | 27.97 | 23.89 | -- | -4.02 | -- |
| Emyria Ltd | 1.39m | -3.14m | 45.97m | -- | -- | 6.57 | -- | 32.96 | -0.0069 | -0.0069 | 0.0031 | 0.0087 | 0.2316 | -- | 40.72 | -- | -52.19 | -82.51 | -69.83 | -106.69 | 1.76 | -17.98 | -225.33 | -355.61 | -- | -22.44 | 0.1037 | -- | -36.68 | 6.60 | 72.57 | -- | -41.45 | -- |
